Prometheus Laboratories

About This Show:




Therapeutics/ Diagnostics/ Oncology and More!

Prometheus is dedicated to improving the lives of people around the world through the development and licensing of innovative therapeutics for the treatment of chronic, challenging medical conditions. With a focus on gastrointestinal and oncology, the goal is to deliver products that enable clinicians to optimize care and make a meaningful difference in their patients’ lives.

Prometheus is committed to developing and applying advanced medical technologies to help clinicians diagnose, characterize and monitor medical conditions in order to tailor the most appropriate intervention strategy for each patient.

Prometheus became part of Nestle Health Science in July 2011.  Nestle Health Science, a fully-owned subsidiary of Nestle S.A., has been operational since January 1, 2011 and has worldwide headquarters in Lutry, Switzerland.  Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages.

Primary Areas of Interest (Based on previous attendees):  Antibodies, ELISA, PCR, Enzymes/Reagents, Electrophoresis, Microarray, Cell Culture, Western Blot, Flow Cytometry, HPLC/LCMS Columns, Pipettors/Tips, QPCR/RTPCR, RNA Purification, Electroporation, Genotyping, Recombinant Proteins.

Primary Science Specialties (Based on previous attendees)  Molecular Biology, Biochemistry, Cell Biology, Cancer Research, Diagnostics, HTS, Lab Automation, Protein Chemistry, Proteomics, Immunology, Genetics, Drug Discovery, Bioinformatics, Microscopy/Imaging, Epigenetics, Cell Signaling/Transduction.


When & Where:

  • When

  • Thursday, December 8, 2016
    11:30 AM - 1:00 PM
    Pacific Time

  • Where

  • Prometheus Laboratories
    Lunch Room
    9410 Carroll Park Drive
    San Diego, California 92121


Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!